ArticleEMBO molecular medicine2019

Anti-VEGF-A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study.

Anne Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.